Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Monkeypox Virus Real-time PCR Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Monkeypox Virus Real-time PCR Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 172 Pages
Report ld: 5347217
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Monkeypox Virus Real-time PCR Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Online Sale accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Monkeypox Virus Real-time PCR Kit leading manufacturers including RayBiotech, GenScript, Creative Biogene, Trivitron, Labnovation, Aurora, CerTest Biotec, FireGene, altona Diagnostics, Vircell, etc., dominate supply; the top five capture approximately % of global revenue, with RayBiotech leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Monkeypox Virus Real-time PCR Kit market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- RayBiotech
- GenScript
- Creative Biogene
- Trivitron
- Labnovation
- Aurora
- CerTest Biotec
- FireGene
- altona Diagnostics
- Vircell
- Tianlong
- Cosmos Biomedical
- BioPerfectus
- Mohammad Ramzan Bhat & Sons
- Genekam
- PerkinElmer
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Human Tonsillar Swab
- Nasopharyngeal Swa
- Serum
- Whole Blood
- Lesion Exudate
- Scab
- Others
Segment by Application
- Online Sale
- Offline Sale
CHAPTER OUTLINE
Chapter 1: Defines the Monkeypox Virus Real-time PCR Kit study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Monkeypox Virus Real-time PCR Kit: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Monkeypox Virus Real-time PCR Kit Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Human Tonsillar Swab
1.2.3 Nasopharyngeal Swa
1.2.4 Serum
1.2.5 Whole Blood
1.2.6 Lesion Exudate
1.2.7 Scab
1.2.8 Others
1.3 Market Segmentation by Application
1.3.1 Global Monkeypox Virus Real-time PCR Kit Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online Sale
1.3.3 Offline Sale
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Monkeypox Virus Real-time PCR Kit Revenue Estimates and Forecasts 2020-2031
2.2 Global Monkeypox Virus Real-time PCR Kit Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Monkeypox Virus Real-time PCR Kit Sales Estimates and Forecasts 2020-2031
2.4 Global Monkeypox Virus Real-time PCR Kit Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Monkeypox Virus Real-time PCR Kit Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Monkeypox Virus Real-time PCR Kit Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Human Tonsillar Swab Market Size by Manufacturers
3.5.2 Nasopharyngeal Swa Market Size by Manufacturers
3.5.3 Serum Market Size by Manufacturers
3.5.4 Whole Blood Market Size by Manufacturers
3.5.5 Lesion Exudate Market Size by Manufacturers
3.5.6 Scab Market Size by Manufacturers
3.5.7 Others Market Size by Manufacturers
3.6 Global Monkeypox Virus Real-time PCR Kit Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Monkeypox Virus Real-time PCR Kit Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Monkeypox Virus Real-time PCR Kit Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Monkeypox Virus Real-time PCR Kit Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Monkeypox Virus Real-time PCR Kit Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Monkeypox Virus Real-time PCR Kit Sales and Revenue by Type (2020-2031)
6.4 North America Monkeypox Virus Real-time PCR Kit Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Monkeypox Virus Real-time PCR Kit Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Monkeypox Virus Real-time PCR Kit Sales and Revenue by Type (2020-2031)
7.4 Europe Monkeypox Virus Real-time PCR Kit Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Monkeypox Virus Real-time PCR Kit Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Monkeypox Virus Real-time PCR Kit Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Monkeypox Virus Real-time PCR Kit Sales and Revenue by Type (2020-2031)
9.4 Central and South America Monkeypox Virus Real-time PCR Kit Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Monkeypox Virus Real-time PCR Kit Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Monkeypox Virus Real-time PCR Kit Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Monkeypox Virus Real-time PCR Kit Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Monkeypox Virus Real-time PCR Kit Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 RayBiotech
11.1.1 RayBiotech Corporation Information
11.1.2 RayBiotech Business Overview
11.1.3 RayBiotech Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.1.4 RayBiotech Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 RayBiotech Monkeypox Virus Real-time PCR Kit Sales by Product in 2024
11.1.6 RayBiotech Monkeypox Virus Real-time PCR Kit Sales by Application in 2024
11.1.7 RayBiotech Monkeypox Virus Real-time PCR Kit Sales by Geographic Area in 2024
11.1.8 RayBiotech Monkeypox Virus Real-time PCR Kit SWOT Analysis
11.1.9 RayBiotech Recent Developments
11.2 GenScript
11.2.1 GenScript Corporation Information
11.2.2 GenScript Business Overview
11.2.3 GenScript Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.2.4 GenScript Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 GenScript Monkeypox Virus Real-time PCR Kit Sales by Product in 2024
11.2.6 GenScript Monkeypox Virus Real-time PCR Kit Sales by Application in 2024
11.2.7 GenScript Monkeypox Virus Real-time PCR Kit Sales by Geographic Area in 2024
11.2.8 GenScript Monkeypox Virus Real-time PCR Kit SWOT Analysis
11.2.9 GenScript Recent Developments
11.3 Creative Biogene
11.3.1 Creative Biogene Corporation Information
11.3.2 Creative Biogene Business Overview
11.3.3 Creative Biogene Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.3.4 Creative Biogene Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Creative Biogene Monkeypox Virus Real-time PCR Kit Sales by Product in 2024
11.3.6 Creative Biogene Monkeypox Virus Real-time PCR Kit Sales by Application in 2024
11.3.7 Creative Biogene Monkeypox Virus Real-time PCR Kit Sales by Geographic Area in 2024
11.3.8 Creative Biogene Monkeypox Virus Real-time PCR Kit SWOT Analysis
11.3.9 Creative Biogene Recent Developments
11.4 Trivitron
11.4.1 Trivitron Corporation Information
11.4.2 Trivitron Business Overview
11.4.3 Trivitron Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.4.4 Trivitron Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Trivitron Monkeypox Virus Real-time PCR Kit Sales by Product in 2024
11.4.6 Trivitron Monkeypox Virus Real-time PCR Kit Sales by Application in 2024
11.4.7 Trivitron Monkeypox Virus Real-time PCR Kit Sales by Geographic Area in 2024
11.4.8 Trivitron Monkeypox Virus Real-time PCR Kit SWOT Analysis
11.4.9 Trivitron Recent Developments
11.5 Labnovation
11.5.1 Labnovation Corporation Information
11.5.2 Labnovation Business Overview
11.5.3 Labnovation Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.5.4 Labnovation Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Labnovation Monkeypox Virus Real-time PCR Kit Sales by Product in 2024
11.5.6 Labnovation Monkeypox Virus Real-time PCR Kit Sales by Application in 2024
11.5.7 Labnovation Monkeypox Virus Real-time PCR Kit Sales by Geographic Area in 2024
11.5.8 Labnovation Monkeypox Virus Real-time PCR Kit SWOT Analysis
11.5.9 Labnovation Recent Developments
11.6 Aurora
11.6.1 Aurora Corporation Information
11.6.2 Aurora Business Overview
11.6.3 Aurora Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.6.4 Aurora Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aurora Recent Developments
11.7 CerTest Biotec
11.7.1 CerTest Biotec Corporation Information
11.7.2 CerTest Biotec Business Overview
11.7.3 CerTest Biotec Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.7.4 CerTest Biotec Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 CerTest Biotec Recent Developments
11.8 FireGene
11.8.1 FireGene Corporation Information
11.8.2 FireGene Business Overview
11.8.3 FireGene Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.8.4 FireGene Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 FireGene Recent Developments
11.9 altona Diagnostics
11.9.1 altona Diagnostics Corporation Information
11.9.2 altona Diagnostics Business Overview
11.9.3 altona Diagnostics Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.9.4 altona Diagnostics Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 altona Diagnostics Recent Developments
11.10 Vircell
11.10.1 Vircell Corporation Information
11.10.2 Vircell Business Overview
11.10.3 Vircell Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.10.4 Vircell Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Vircell Recent Developments
11.11 Tianlong
11.11.1 Tianlong Corporation Information
11.11.2 Tianlong Business Overview
11.11.3 Tianlong Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.11.4 Tianlong Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Tianlong Recent Developments
11.12 Cosmos Biomedical
11.12.1 Cosmos Biomedical Corporation Information
11.12.2 Cosmos Biomedical Business Overview
11.12.3 Cosmos Biomedical Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.12.4 Cosmos Biomedical Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Cosmos Biomedical Recent Developments
11.13 BioPerfectus
11.13.1 BioPerfectus Corporation Information
11.13.2 BioPerfectus Business Overview
11.13.3 BioPerfectus Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.13.4 BioPerfectus Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 BioPerfectus Recent Developments
11.14 Mohammad Ramzan Bhat & Sons
11.14.1 Mohammad Ramzan Bhat & Sons Corporation Information
11.14.2 Mohammad Ramzan Bhat & Sons Business Overview
11.14.3 Mohammad Ramzan Bhat & Sons Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.14.4 Mohammad Ramzan Bhat & Sons Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Mohammad Ramzan Bhat & Sons Recent Developments
11.15 Genekam
11.15.1 Genekam Corporation Information
11.15.2 Genekam Business Overview
11.15.3 Genekam Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.15.4 Genekam Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Genekam Recent Developments
11.16 PerkinElmer
11.16.1 PerkinElmer Corporation Information
11.16.2 PerkinElmer Business Overview
11.16.3 PerkinElmer Monkeypox Virus Real-time PCR Kit Product Models, Descriptions and Specifications
11.16.4 PerkinElmer Monkeypox Virus Real-time PCR Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 PerkinElmer Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Monkeypox Virus Real-time PCR Kit Industry Chain
12.2 Monkeypox Virus Real-time PCR Kit Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Monkeypox Virus Real-time PCR Kit Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Monkeypox Virus Real-time PCR Kit Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Monkeypox Virus Real-time PCR Kit Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Monkeypox Virus Real-time PCR Kit Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Monkeypox Virus Real-time PCR Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Monkeypox Virus Real-time PCR Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Monkeypox Virus Real-time PCR Kit Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Monkeypox Virus Real-time PCR Kit Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Monkeypox Virus Real-time PCR Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Monkeypox Virus Real-time PCR Kit Sales by Region (2020-2025) & (K Units)
Table 8. Global Monkeypox Virus Real-time PCR Kit Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Monkeypox Virus Real-time PCR Kit Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Monkeypox Virus Real-time PCR Kit Sales Share by Manufacturers (2020-2025)
Table 12. Global Monkeypox Virus Real-time PCR Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Monkeypox Virus Real-time PCR Kit Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Monkeypox Virus Real-time PCR Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Virus Real-time PCR Kit as of 2024)
Table 16. Global Monkeypox Virus Real-time PCR Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Monkeypox Virus Real-time PCR Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Monkeypox Virus Real-time PCR Kit Manufacturing Base and Headquarters
Table 19. Global Monkeypox Virus Real-time PCR Kit Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Monkeypox Virus Real-time PCR Kit Sales by Type (2020-2025) & (K Units)
Table 23. Global Monkeypox Virus Real-time PCR Kit Sales by Type (2026-2031) & (K Units)
Table 24. Global Monkeypox Virus Real-time PCR Kit Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Monkeypox Virus Real-time PCR Kit Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Monkeypox Virus Real-time PCR Kit ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Monkeypox Virus Real-time PCR Kit Sales by Application (2020-2025) & (K Units)
Table 29. Global Monkeypox Virus Real-time PCR Kit Sales by Application (2026-2031) & (K Units)
Table 30. Monkeypox Virus Real-time PCR Kit High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Monkeypox Virus Real-time PCR Kit Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Monkeypox Virus Real-time PCR Kit Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Monkeypox Virus Real-time PCR Kit ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Monkeypox Virus Real-time PCR Kit Growth Accelerators and Market Barriers
Table 37. North America Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Monkeypox Virus Real-time PCR Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Monkeypox Virus Real-time PCR Kit Growth Accelerators and Market Barriers
Table 40. Europe Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Monkeypox Virus Real-time PCR Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Monkeypox Virus Real-time PCR Kit Growth Accelerators and Market Barriers
Table 45. Southeast Asia Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Monkeypox Virus Real-time PCR Kit Investment Opportunities and Key Challenges
Table 47. Central and South America Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Monkeypox Virus Real-time PCR Kit Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Monkeypox Virus Real-time PCR Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. RayBiotech Corporation Information
Table 51. RayBiotech Description and Major Businesses
Table 52. RayBiotech Product Models, Descriptions and Specifications
Table 53. RayBiotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. RayBiotech Sales Value Proportion by Product in 2024
Table 55. RayBiotech Sales Value Proportion by Application in 2024
Table 56. RayBiotech Sales Value Proportion by Geographic Area in 2024
Table 57. RayBiotech Monkeypox Virus Real-time PCR Kit SWOT Analysis
Table 58. RayBiotech Recent Developments
Table 59. GenScript Corporation Information
Table 60. GenScript Description and Major Businesses
Table 61. GenScript Product Models, Descriptions and Specifications
Table 62. GenScript Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. GenScript Sales Value Proportion by Product in 2024
Table 64. GenScript Sales Value Proportion by Application in 2024
Table 65. GenScript Sales Value Proportion by Geographic Area in 2024
Table 66. GenScript Monkeypox Virus Real-time PCR Kit SWOT Analysis
Table 67. GenScript Recent Developments
Table 68. Creative Biogene Corporation Information
Table 69. Creative Biogene Description and Major Businesses
Table 70. Creative Biogene Product Models, Descriptions and Specifications
Table 71. Creative Biogene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Creative Biogene Sales Value Proportion by Product in 2024
Table 73. Creative Biogene Sales Value Proportion by Application in 2024
Table 74. Creative Biogene Sales Value Proportion by Geographic Area in 2024
Table 75. Creative Biogene Monkeypox Virus Real-time PCR Kit SWOT Analysis
Table 76. Creative Biogene Recent Developments
Table 77. Trivitron Corporation Information
Table 78. Trivitron Description and Major Businesses
Table 79. Trivitron Product Models, Descriptions and Specifications
Table 80. Trivitron Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Trivitron Sales Value Proportion by Product in 2024
Table 82. Trivitron Sales Value Proportion by Application in 2024
Table 83. Trivitron Sales Value Proportion by Geographic Area in 2024
Table 84. Trivitron Monkeypox Virus Real-time PCR Kit SWOT Analysis
Table 85. Trivitron Recent Developments
Table 86. Labnovation Corporation Information
Table 87. Labnovation Description and Major Businesses
Table 88. Labnovation Product Models, Descriptions and Specifications
Table 89. Labnovation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Labnovation Sales Value Proportion by Product in 2024
Table 91. Labnovation Sales Value Proportion by Application in 2024
Table 92. Labnovation Sales Value Proportion by Geographic Area in 2024
Table 93. Labnovation Monkeypox Virus Real-time PCR Kit SWOT Analysis
Table 94. Labnovation Recent Developments
Table 95. Aurora Corporation Information
Table 96. Aurora Description and Major Businesses
Table 97. Aurora Product Models, Descriptions and Specifications
Table 98. Aurora Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Aurora Recent Developments
Table 100. CerTest Biotec Corporation Information
Table 101. CerTest Biotec Description and Major Businesses
Table 102. CerTest Biotec Product Models, Descriptions and Specifications
Table 103. CerTest Biotec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. CerTest Biotec Recent Developments
Table 105. FireGene Corporation Information
Table 106. FireGene Description and Major Businesses
Table 107. FireGene Product Models, Descriptions and Specifications
Table 108. FireGene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. FireGene Recent Developments
Table 110. altona Diagnostics Corporation Information
Table 111. altona Diagnostics Description and Major Businesses
Table 112. altona Diagnostics Product Models, Descriptions and Specifications
Table 113. altona Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. altona Diagnostics Recent Developments
Table 115. Vircell Corporation Information
Table 116. Vircell Description and Major Businesses
Table 117. Vircell Product Models, Descriptions and Specifications
Table 118. Vircell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Vircell Recent Developments
Table 120. Tianlong Corporation Information
Table 121. Tianlong Description and Major Businesses
Table 122. Tianlong Product Models, Descriptions and Specifications
Table 123. Tianlong Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Tianlong Recent Developments
Table 125. Cosmos Biomedical Corporation Information
Table 126. Cosmos Biomedical Description and Major Businesses
Table 127. Cosmos Biomedical Product Models, Descriptions and Specifications
Table 128. Cosmos Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Cosmos Biomedical Recent Developments
Table 130. BioPerfectus Corporation Information
Table 131. BioPerfectus Description and Major Businesses
Table 132. BioPerfectus Product Models, Descriptions and Specifications
Table 133. BioPerfectus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. BioPerfectus Recent Developments
Table 135. Mohammad Ramzan Bhat & Sons Corporation Information
Table 136. Mohammad Ramzan Bhat & Sons Description and Major Businesses
Table 137. Mohammad Ramzan Bhat & Sons Product Models, Descriptions and Specifications
Table 138. Mohammad Ramzan Bhat & Sons Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Mohammad Ramzan Bhat & Sons Recent Developments
Table 140. Genekam Corporation Information
Table 141. Genekam Description and Major Businesses
Table 142. Genekam Product Models, Descriptions and Specifications
Table 143. Genekam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Genekam Recent Developments
Table 145. PerkinElmer Corporation Information
Table 146. PerkinElmer Description and Major Businesses
Table 147. PerkinElmer Product Models, Descriptions and Specifications
Table 148. PerkinElmer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. PerkinElmer Recent Developments
Table 150. Key Raw Materials Distribution
Table 151. Raw Materials Key Suppliers
Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 153. Milestones in Production Technology Evolution
Table 154. Distributors List
Table 155. Market Trends and Market Evolution
Table 156. Market Drivers and Opportunities
Table 157. Market Challenges, Risks, and Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Monkeypox Virus Real-time PCR Kit Product Picture
Figure 2. Global Monkeypox Virus Real-time PCR Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Human Tonsillar Swab Product Picture
Figure 4. Nasopharyngeal Swa Product Picture
Figure 5. Serum Product Picture
Figure 6. Whole Blood Product Picture
Figure 7. Lesion Exudate Product Picture
Figure 8. Scab Product Picture
Figure 9. Others Product Picture
Figure 10. Global Monkeypox Virus Real-time PCR Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 11. Online Sale
Figure 12. Offline Sale
Figure 13. Monkeypox Virus Real-time PCR Kit Report Years Considered
Figure 14. Global Monkeypox Virus Real-time PCR Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 16. Global Monkeypox Virus Real-time PCR Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Monkeypox Virus Real-time PCR Kit Revenue Market Share by Region (2020-2031)
Figure 18. Global Monkeypox Virus Real-time PCR Kit Sales (2020-2031) & (K Units)
Figure 19. Global Monkeypox Virus Real-time PCR Kit Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global Monkeypox Virus Real-time PCR Kit Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers Monkeypox Virus Real-time PCR Kit Sales Volume Market Share in 2024
Figure 22. Global Monkeypox Virus Real-time PCR Kit Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Human Tonsillar Swab Revenue Market Share by Manufacturer in 2024
Figure 25. Nasopharyngeal Swa Revenue Market Share by Manufacturer in 2024
Figure 26. Serum Revenue Market Share by Manufacturer in 2024
Figure 27. Whole Blood Revenue Market Share by Manufacturer in 2024
Figure 28. Lesion Exudate Revenue Market Share by Manufacturer in 2024
Figure 29. Scab Revenue Market Share by Manufacturer in 2024
Figure 30. Others Revenue Market Share by Manufacturer in 2024
Figure 31. Global Monkeypox Virus Real-time PCR Kit Sales Market Share by Type (2020-2031)
Figure 32. Global Monkeypox Virus Real-time PCR Kit Revenue Market Share by Type (2020-2031)
Figure 33. Global Monkeypox Virus Real-time PCR Kit Sales Market Share by Application (2020-2031)
Figure 34. Global Monkeypox Virus Real-time PCR Kit Revenue Market Share by Application (2020-2031)
Figure 35. North America Monkeypox Virus Real-time PCR Kit Sales YoY (2020-2031) & (K Units)
Figure 36. North America Monkeypox Virus Real-time PCR Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) in 2024
Figure 38. North America Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 39. North America Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Application (2020-2031)
Figure 41. North America Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Monkeypox Virus Real-time PCR Kit Sales YoY (2020-2031) & (K Units)
Figure 46. Europe Monkeypox Virus Real-time PCR Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) in 2024
Figure 48. Europe Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Type (2020-2031)
Figure 49. Europe Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Application (2020-2031)
Figure 51. Europe Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 53. France Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales YoY (2020-2031) & (K Units)
Figure 58. Asia-Pacific Monkeypox Virus Real-time PCR Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 61. Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Application (2020-2031)
Figure 63. Asia-Pacific Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 68. India Monkeypox Virus Real-time PCR Kit Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Monkeypox Virus Real-time PCR Kit Sales YoY (2020-2031) & (K Units)
Figure 70. Central and South America Monkeypox Virus Real-time PCR Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Type (2021-2031)
Figure 73. Central and South America Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Application (2020-2031)
Figure 75. Central and South America Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Monkeypox Virus Real-time PCR Kit Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Monkeypox Virus Real-time PCR Kit Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Monkeypox Virus Real-time PCR Kit Sales YoY (2020-2031) & (K Units)
Figure 79. Middle East and Africa Monkeypox Virus Real-time PCR Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Type (2021-2031)
Figure 82. South America Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Monkeypox Virus Real-time PCR Kit Sales Volume (K Units) by Application (2020-2031)
Figure 84. Middle East and Africa Monkeypox Virus Real-time PCR Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Monkeypox Virus Real-time PCR Kit Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Monkeypox Virus Real-time PCR Kit Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Monkeypox Virus Real-time PCR Kit Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Monkeypox Virus Real-time PCR Kit Revenue (2020-2025) & (US$ Million)
Figure 89. Monkeypox Virus Real-time PCR Kit Industry Chain Mapping
Figure 90. Regional Monkeypox Virus Real-time PCR Kit Manufacturing Base Distribution (%)
Figure 91. Global Monkeypox Virus Real-time PCR Kit Production Market Share by Region (2020-2031)
Figure 92. Monkeypox Virus Real-time PCR Kit Production Process
Figure 93. Regional Monkeypox Virus Real-time PCR Kit Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Monkeypox Virus Real-time PCR Kit market?
The top companies in the global Monkeypox Virus Real-time PCR Kit market are RayBiotech、GenScript、Creative Biogene.
Related Reports
Monkeypox Virus Real-time PCR Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Monkeypox Virus Real-time PCR Kit was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 150
USD 3950.00
(Single User License)
Global Monkeypox Virus Real-time PCR Kit Market Research Report 2026
The global Monkeypox Virus Real-time PCR Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 129
USD 2900.00
(Single User License)
Global Monkeypox Virus Real-time PCR Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Monkeypox Virus Real-time PCR Kit market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 109
USD 4250.00
(Single User License)
Monkeypox Virus Real-time PCR Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Monkeypox Virus Real-time PCR Kit was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 141
USD 3950.00
(Single User License)
Global Monkeypox Virus Real-time PCR Kit Market Research Report 2025
The global market for Monkeypox Virus Real-time PCR Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 103
USD 2900.00
(Single User License)
Global Monkeypox Virus Real-Time PCR Kit Market Insights, Forecast to 2030
A Monkeypox Virus Real-Time PCR Kit is a diagnostic tool used to detect and identify the presence of monkeypox virus in biological samples. Monkeypox is a viral disease that primarily affects animals, particularly monkeys, but can also be transmitted to humans.
Published Date: 2024-04-27
Pages: 112
USD 4900.00
(Single User License)
Global Monkeypox Virus Real-time PCR Kit Market Insights, Forecast to 2030
The global Monkeypox Virus Real-time PCR Kit market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 114
USD 4900.00
(Single User License)
Global Monkeypox Virus Real-Time PCR Kit Market Research Report 2024
A Monkeypox Virus Real-Time PCR Kit is a diagnostic tool used to detect and identify the presence of monkeypox virus in biological samples. Monkeypox is a viral disease that primarily affects animals, particularly monkeys, but can also be transmitted to humans.
Published Date: 2024-01-19
Pages: 92
USD 2900.00
(Single User License)
Global Monkeypox Virus Real-time PCR Kit Market Research Report 2024
The global Monkeypox Virus Real-time PCR Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 103
USD 2900.00
(Single User License)
Monkeypox Virus Real-Time PCR Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Monkeypox Virus Real-Time PCR Kit is a diagnostic tool used to detect and identify the presence of monkeypox virus in biological samples. Monkeypox is a viral disease that primarily affects animals, particularly monkeys, but can also be transmitted to humans.
Published Date: 2024-01-13
Pages: 124
USD 3950.00
(Single User License)
Monkeypox Virus Real-time PCR Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Monkeypox Virus Real-time PCR Kit was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 150
USD 3950.00 (Single User License)Global Monkeypox Virus Real-time PCR Kit Market Research Report 2026
The global Monkeypox Virus Real-time PCR Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 129
USD 2900.00 (Single User License)Global Monkeypox Virus Real-time PCR Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Monkeypox Virus Real-time PCR Kit market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 109
USD 4250.00 (Single User License)Monkeypox Virus Real-time PCR Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Monkeypox Virus Real-time PCR Kit was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 141
USD 3950.00 (Single User License)Global Monkeypox Virus Real-time PCR Kit Market Research Report 2025
The global market for Monkeypox Virus Real-time PCR Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 103
USD 2900.00 (Single User License)Global Monkeypox Virus Real-Time PCR Kit Market Insights, Forecast to 2030
A Monkeypox Virus Real-Time PCR Kit is a diagnostic tool used to detect and identify the presence of monkeypox virus in biological samples. Monkeypox is a viral disease that primarily affects animals, particularly monkeys, but can also be transmitted to humans.
Published: 2024-04-27
Pages: 112
USD 4900.00 (Single User License)Global Monkeypox Virus Real-time PCR Kit Market Insights, Forecast to 2030
The global Monkeypox Virus Real-time PCR Kit market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 114
USD 4900.00 (Single User License)Global Monkeypox Virus Real-Time PCR Kit Market Research Report 2024
A Monkeypox Virus Real-Time PCR Kit is a diagnostic tool used to detect and identify the presence of monkeypox virus in biological samples. Monkeypox is a viral disease that primarily affects animals, particularly monkeys, but can also be transmitted to humans.
Published: 2024-01-19
Pages: 92
USD 2900.00 (Single User License)Global Monkeypox Virus Real-time PCR Kit Market Research Report 2024
The global Monkeypox Virus Real-time PCR Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 103
USD 2900.00 (Single User License)Monkeypox Virus Real-Time PCR Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Monkeypox Virus Real-Time PCR Kit is a diagnostic tool used to detect and identify the presence of monkeypox virus in biological samples. Monkeypox is a viral disease that primarily affects animals, particularly monkeys, but can also be transmitted to humans.
Published: 2024-01-13
Pages: 124
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now